AML Tuesday’s Session #16 on: Conducting a
1 / 1

AML Tuesday’s Session #16 on: Conducting a

Author : briana-ranney | Published Date : 2025-05-28

Description: AML Tuesdays Session 16 on Conducting a Business Risk Assessment 23 May 2023 Agenda Financial Transparency Advisors BRA Overview Financial Transparency Advisors Business Risk Assessment Financial Transparency Advisors Why DNFBPs

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "AML Tuesday’s Session #16 on: Conducting a" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Transcript:AML Tuesday’s Session #16 on: Conducting a:
AML Tuesday’s Session #16 on: Conducting a Business Risk Assessment 23 May 2023 Agenda © Financial Transparency Advisors BRA Overview © Financial Transparency Advisors Business Risk Assessment © Financial Transparency Advisors Why DNFBPs need Business Risk Assessment © Financial Transparency Advisors Regulatory Framework and International Standards © Financial Transparency Advisors Monegasque AML Law – Article 3 requires FIs and DNFBPs to assess and understand the risks of ML/TF. Institutions and professionals shall develop a risk assessment depending on the nature of products/services, transactions, delivery channels, customers, and geography. FATF recommendation 1 – FIs and DNFBPs are required to take appropriate steps to identify and assess ML/TF risks. The risk assessment shall be documented. The risk assessment should be appropriate to the nature and size of the business. FATF guidance – RBA guidance for Money or Value Transfer Services, RBA to prepaid cards, mobile payments and internet-based payment services Wolfsberg Q&A on Risk Assessment for ML, Sanctions, Bribery & Corruption The Difference between BRA and CRA © Financial Transparency Advisors BRA Overview © Financial Transparency Advisors BRA Overview (Cont.) © Financial Transparency Advisors BRA Document Shall describe Overall risks and introduction of the Institution (NRA, Governance products and Services offered by the Institution, general overview) The Methodology for Inherent risk determination The Methodology for Control Assessment and residual risk calculation Description of Inherent Risk including Quantitative and Qualitative Data Description of Controls and Risk Mitigation Action Plan Defined to Mitigate Risks BRA Stages 01 02 04 03 05 Gathering information NRA, Internal quantitative data, Qualitative data Data Collection Analyzing Data Collected and assigning Inherent Risk Assessing Controls and defining Residual Risk Risk Assessment Increasing Resources Introducing New Controls Enhancing Existing Controls Risk Response - Action Plan Adoption of RBA and proposed Action Plan by Senior Management Alignment with Risk Appetite Adopting BRA Updating Information Annually and based on new developments internal/external Monitoring BRA Data Sources © Financial Transparency Advisors BRA Data Sources © Financial Transparency Advisors High Level Risks International organization Guidance on risks, typologies, Mutual Evaluations NRA Sectorial Risk Assessments Individual Risks Related to Each Risk Category Number of Customers, Volume of Transactions per risk category STR Correspondent Requests Court requests FIU Requests BRA Risk Factors - Customers © Financial Transparency Advisors Quantitative Information Number of Customers Volume of Transactions Volume of Assets Internal Information (STR, Correspondent Requests, FIU requests, Court Requests) BRA Risk Factors – Products and Services ©

Download Document

Here is the link to download the presentation.
"AML Tuesday’s Session #16 on: Conducting a"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Presentations

How to make sense of genetic studies in AML and MDS AML Training Program Conducting A Live Strategy Session Welcome to Choral Conducting Session  Key Takeaways Insights On Oversight: A Regulatory Roundtable on AML Trends and Mutations and AML: Sampling, Assays, The new (2021) ELN AML MRD guidelines AML 	 Elizabeth Ellent  Some slides borrowed from Dr. Richard Stone and Dr. Naval Mastercard®  AML Net Organizations can’t afford to be Acute myeloid leukemia (AML) CLASSIFICATION OF AML  & A  Better   AML  Supervisory AML Accelerate Programme